Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Exercise Tolerance in IPF
NCT00359736Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jul 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in idiopathic pulmonary fibrosis (IPF), sponsored by VA Office of Research & Development. Started Jul 2006; status: completed.
02
Drugs
sildenafil
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT00359736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359736.